A biomimetic chondrocyte membrane-camouflaged tFNA nanoplatform for reprogramming the cartilage–synovium axis in osteoarthritis
Materials Today Bio · 2026-10 · 40 · 103609
DOI: 10.1016/j.mtbio.2026.103609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2026-10. Verfasst von Zhen Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoarthritis (OA) is a whole-joint disorder characterized by progressive cartilage degeneration and synovial remodeling, yet effective disease-modifying therapies remain unavailable. Mitochondrial dysfunction-driven chondrocyte senescence is increasingly recognized as a key driver of cartilage degeneration and pathological cartilage-synovium crosstalk. Here, we engineered a biomimetic, programmable nanoplatform, termed CM@THC, by loading hesperidin, a natural flavonoid with potent antioxidant activity, into tetrahedral framework nucleic acids (tFNAs) and subsequently cloaking the nanocomplex with chondrocyte membranes (CMs). This hierarchical design combines the programmable drug-delivery capacity of tFNAs with the homologous targeting and biointerfacial properties of membrane camouflage, thereby improving nanocomplex stability, cellular internalization, and intra-articular retention. Functionally, CM@THC restored redox homeostasis and PINK1/Parkin-associated mitophagy in IL-1β-stimulated chondrocytes, attenuating cellular senescence and extracellular matrix imbalance while limiting the secondary profibrotic activation of fibroblast-like synoviocytes (FLSs). Collectively, these findings establish a membrane-camouflaged tFNA strategy for natural-product delivery and identify CM@THC as a biomimetic, mitochondria-protective nanotherapeutic that disrupts the pathological cartilage-synovium axis in OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Li, Y., Ye, M., Liu, H., Huang, Q., Wang, X., Shen, M., Xu, S., & Li, J. (2026). A biomimetic chondrocyte membrane-camouflaged tFNA nanoplatform for reprogramming the cartilage–synovium axis in osteoarthritis. Materials Today Bio, 40, 103609. https://doi.org/10.1016/j.mtbio.2026.103609
Vancouver
Zhang Z, Li Y, Ye M, Liu H, Huang Q, Wang X, et al. A biomimetic chondrocyte membrane-camouflaged tFNA nanoplatform for reprogramming the cartilage–synovium axis in osteoarthritis. Materials Today Bio. 2026;40:103609. doi:10.1016/j.mtbio.2026.103609
BibTeX
@article{Zhang2026,
author = {Zhang, Zhen and Li, Yifan and Ye, Meihan and Liu, Hanqing and Huang, Qianshuo and Wang, Xuanwei and Shen, Miaoda and Xu, Sanzhong and Li, Jiafeng},
title = {A biomimetic chondrocyte membrane-camouflaged tFNA nanoplatform for reprogramming the cartilage–synovium axis in osteoarthritis},
journal = {Materials Today Bio},
year = {2026},
volume = {40},
pages = {103609},
doi = {10.1016/j.mtbio.2026.103609}
}
EUVIMED